23
Formation INFAS. Module de PEDOPSYCHIATRIE. Année 2021/2022

1- Antoine PELISSOLO. Troubles anxieux et névrotiques. EMC de Psychiatrie, 2012 S1634- 6939(12)48040-1.
2-Julien-Daniel GUELFI et Frédéric ROUILLON. Livre Manuel de psychiatrie. Edition,Masson 2012

MOUREN SIMEONI MC, VILA G , VERAL L. (1993) – Troubles anxieux de l’enfant et de l’adolescent. Maloine, Paris, 152 p.

Canadian Psychiatric Association. Canadian Clinical Practice Guidelines for the Treatment of Depressive Disorders. Can J Psychiatry 2001;46:Supp1.
2 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC: American Psychiatric Association, 1994.
3 Bland RC. Epidemiology of affective disorders: a review. Can J Psychiatry 1997;42:367-377.
4 Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994; 51:8-19.
5 Document de Stephens T, Joubert N et ???.
6 Fogarty F, Russell JM, Newman SC, Bland RC. Mania. Acta Psychiatr Scand 1994;Suppl376:16-23.
7 Judd LL, Paulus MP, Wells KB, Rapaport MH. Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. Am J Psychiatry 1996;153:1411- 7.
8 Murray CJL, Lopez AD, Eds. Summary: The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cam- bridge, MA: Published by the Harvard School of Public Health on behalf of the World Health Organization and the World Bank, Harvard University Press, 1996. http://www.who.int/msa/mnh/ems/dalys/into.htm
9 Horwath E, Weissman MM. Epidemiology of depression and anxiety disorders. In: Tsuang MT, Tohen M, Zahner GEP, Eds. Textbook in psychiatric epidemiology. New York: Wiley-Liss. 1995. p317-44.
10 Klein DN, Schwartz JE, Rose S, Leader JB. Five-year course and outcome of dysthymic disorder: a prospective, naturalistic follow-up study. Am J Psychiatry 2000; 157:931-9.
11 Mintz J, Mintz LI, Arruda MJ, Hwang, SS. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 1992;49:761-8.
12 Griffiths J, Ravindran AV, Merali, Anisman H. Dysthymia: a review of pharmacological and behavioral factors. Mol Psychiatry 2000; 5:242-61.
13 Spaner D, Bland RC, Newman SC. Major depressive disorder. Acta Psychiatr Scand 1994;Suppl 376:7-15.
14 De Marco RR. The epidemiology of major depression: implications of occurrence, recurrence, and stress in a Canadian community sample. Can J Psychiatry 2000;45:67-74.
15 Patten SB. Long-term medical conditions and major depression in the Canadian population. Canadian Journal of Psychiatry 1999;44:151-7.
16 Beaudet MP. Depression. Health Reports 1996;7(4):11-24.
17 Bland RC. Psychiatry and the burden of mental illness. Can J Psychiatry 1998; 43:801-10.
18 Schoenbaum M, Un!tzer J, Sherbourne C, Duan N, Rubenstein LV, Mirand J et al. Cost-effectiveness of
practice-initiated quality improvement for depression: Results of a randomized controlled trial. JAMA 2001;286:11:1325-30.
47